dc.contributor | IDrug GmbH | |
dc.contributor | Leibniz Institute of Plant Biochemistry | |
dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-27T11:26:27Z | |
dc.date.available | 2014-05-27T11:26:27Z | |
dc.date.created | 2014-05-27T11:26:27Z | |
dc.date.issued | 2012-04-30 | |
dc.identifier | Latin American Journal of Pharmacy, v. 31, n. 1, p. 91-96, 2012. | |
dc.identifier | 0326-2383 | |
dc.identifier | http://hdl.handle.net/11449/73298 | |
dc.identifier | 2-s2.0-84860125323 | |
dc.description.abstract | Comparative HPLC-UV and LC-MS/MS studies of impurity profiles of a reference sample (Xenical®, F. Hoffmann-La Roche Ltd., Switzerland) vs. generic (Lipiblock®, EMS-Sigma Pharma, a generic drug) were carried out with ethanol extracts of commercial samples. The generic formulation contained higher levels of common impurities as well as a considerable number of impurities not found in the reference product. The detected impurity profile of Lipiblock® revealed that it most likely is based on fermentation. Since the effect of the impurities is unknown, at this point fully synthetic Xenical® appears to offer a better safety margin than Lipiblock® which, however, compares quite well to other generic formulations. | |
dc.language | eng | |
dc.relation | Latin American Journal of Pharmacy | |
dc.relation | 0.401 | |
dc.relation | 0,152 | |
dc.rights | Acesso restrito | |
dc.source | Scopus | |
dc.subject | Generics | |
dc.subject | HPLC-MS/MS | |
dc.subject | HPLC-UV | |
dc.subject | Orlistat | |
dc.subject | cobese | |
dc.subject | generic drug | |
dc.subject | lipiblock | |
dc.subject | orsoten | |
dc.subject | rotipuran | |
dc.subject | suprapur | |
dc.subject | tetrahydrolipstatin | |
dc.subject | unclassified drug | |
dc.subject | controlled study | |
dc.subject | drug formulation | |
dc.subject | drug impurity | |
dc.subject | drug safety | |
dc.subject | drug structure | |
dc.subject | fermentation | |
dc.subject | high performance liquid chromatography | |
dc.subject | intermethod comparison | |
dc.subject | liquid chromatography | |
dc.subject | mass spectrometry | |
dc.title | Comparison of impurity profiles of lipiblock® vs. orlistat using HPLC and LC-MS/MS | |
dc.type | Artículos de revistas | |